BioAdvance News

BioAdvance Portfolio Generated $450M in Fiscal 2014

By WebmasterJune 12, 2014November 1st, 2024No Comments

BioAdvance Portfolio Generated $450M in Fiscal 2014
Read more here

Previous PostRelmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction
Next PostHealthQx Expands, Fueled by a New Round of Funding